tirzepatide other names alternate names for tirzepatide and

this complete loss of CDC73 activity is a necessary but not sufficient cause for parathyroid carcinoma in these patients, but with other changes leading to a cancer phenotype. From the Deputy Editor of Endocrine Reviews Endocrine Reviews E

N Engl J Med Evid 4:EVIDoa2500173 Rivera Gutierrez R, Tama E, Bechenati D et al (2025) Effect of Tirzepatide on body weight and diabetes control in adults with type 1 diabetes and overweight or obesity

The main risks include increased potential for hypoglycaemia (especially with other diabetes medications), dehydration from combined fluid loss effects, and the need for kidney function monitoring

PlexusDx provides 24/7 support to guide patients through overdose events and coordinate care

[DOI] [PubMed] [Google Scholar] Kim SJ, Choi WS, Han JS, Warnock G, Fedida D, McIntosh CH